ACI-200

Product Introduction ACI-200

• Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) with marked anti-inflammatory and analgesic properties. It is reported to have a higher anti-inflammatory action or at least comparable effects than conventional NSAIDs in double-blind studies.
• Aceclofenac potently inhibits the cyclo-oxygenase enzyme (COX) that is involved in the synthesis of prostaglandins, which are inflammatory mediators that cause pain, swelling, inflammation, and fever. It is orally administered for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Aceclofenac belongs to BCS Class II as it possesses poor aqueous solubility.
• Aceclofenac displays high permeability to penetrate into synovial joints where in patients with osteoarthritis and related conditions, the loss of articular cartilage in the area causes joint pain, tenderness, stiffness, crepitus, and local inflammation.Aceclofenac is also reported to be effective in other painful conditions such as dental and gynaecological conditions. Aceclofenac was developed as an analog of a commonly prescribed NSAID.

Indication of ACI-200

• Aceclofenac Indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Side Effects

• Common side effects are Somnolence, diarrhoea, heartburn, dyspepsia, nausea, vomiting, abdominal pain and flatulence.